Related Experiment Video
Updated: Jul 4, 2026
Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
A Prospective Case-Control Study of Helicobacter pylori and Systemic Inflammation in Colorectal Cancer Pathogenesis
Imad Sibhai1, Mounika Kotte2, Abubakar Gapizov3
1Medical Education, Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Ahmedabad, IND.
Abstract:
Background The role of Helicobacter pylori in colorectal cancer (CRC) remains controversial, while systemic inflammation drives carcinogenesis. We evaluated independent and interactive associations of active H. pylori infection and neutrophil-to-lymphocyte ratio (NLR) with CRC risk. Methods This prospective case-control study at Jinnah Hospital, Lahore, Pakistan, from August 2023 to August 2025, enrolled 105 treatment-naïve CRC patients and 210 age- and sex-matched controls with normal colonoscopy. Active H. pylori infection was determined by stool antigen testing. NLR was dichotomized at the cohort median (2.5). Multivariate logistic regression simultaneously adjusted for age, sex, smoking, diabetes, and body mass index. Results H. pylori prevalence did not differ between cases (58/105, 55.2%) and controls (105/210, 50.0%) (χ² = 0.769, p = 0.380). High NLR (>2.5) was present in 66/105 (62.9%) cases vs. 18/210 (8.6%) controls (χ² = 105.487, p < 0.001). After adjustment, high NLR was strongly associated with CRC (aOR = 300.86; 95% CI: 60.85-1487.58; p < 0.001; AUC = 0.792). The extremely wide confidence interval reflects sparse data (only 18 controls had high NLR), warranting cautious interpretation. A significant negative interaction was observed between H. pylori and high NLR (aOR = 0.245; 95% CI: 0.131-0.459; p < 0.001). The model explained 52.5% of variance (Nagelkerke R²) and correctly classified 83.5% of participants. Conclusion Elevated NLR is strongly associated with CRC in this Pakistani cohort, while active H. pylori infection shows no significant direct association. The negative interaction suggests host inflammatory status may modify H. pylori effects, though confirmation in larger studies is needed. Because of the case-control design with NLR measured after CRC diagnosis, reverse causation cannot be excluded. NLR measurement offers a simple, cost-effective tool for CRC risk stratification.
Related Concept Videos
01:26Gastritis II: Pathophysiology
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:24Peptic Ulcer Disease II: Pathophysiology
01:28Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...